Siena S - Search Results

1

Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year results.

Gianni AM, Siena S, Bregni M, Di Nicola M, Orefice S, Cusumano F, Salvadori B, Luini A, Greco M, Zucali R, Rilke F, Zambetti M, Valagussa P, Bonadonna G. Gianni AM, et al. Among authors: siena s. J Clin Oncol. 1997 Jun;15(6):2312-21. doi: 10.1200/JCO.1997.15.6.2312. J Clin Oncol. 1997. PMID: 9196145 Clinical Trial.

2

Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients.

Gianni AM, Bregni M, Siena S, Magni M, Di Nicola M, Lombardi F, Tarella C, Pileri A, Bonadonna G. Gianni AM, et al. Among authors: siena s. J Clin Oncol. 1992 Dec;10(12):1955-62. doi: 10.1200/JCO.1992.10.12.1955. J Clin Oncol. 1992. PMID: 1280674

3

The use of GM-CSF and peripheral blood stem cells (PBSC) minimises haematological toxicity following a myeloablative course of chemo-radiotherapy.

Gianni AM, Siena S, Bregni M, Bonadonna G. Gianni AM, et al. Among authors: siena s. Pathol Biol (Paris). 1992 Nov;39(9):956. Pathol Biol (Paris). 1992. PMID: 1347166 No abstract available.

4

Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer.

Bregni M, Magni M, Siena S, Di Nicola M, Bonadonna G, Gianni AM. Bregni M, et al. Among authors: siena s. Blood. 1992 Sep 15;80(6):1418-22. Blood. 1992. PMID: 1520868 Free article.

5

Recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor administered in vivo after high-dose cyclophosphamide cancer chemotherapy: effect on hematopoiesis and microenvironment in human bone marrow.

Orazi A, Cattoretti G, Schiró R, Siena S, Bregni M, Di Nicola M, Gianni AM. Orazi A, et al. Among authors: siena s. Blood. 1992 May 15;79(10):2610-9. Blood. 1992. PMID: 1586713 Free article.

6

Hematopoietic stem cell transplantation in the treatment of lymphoma.

Bregni M, Siena S. Bregni M, et al. Among authors: siena s. Curr Opin Oncol. 1991 Oct;3(5):838-42. doi: 10.1097/00001622-199110000-00006. Curr Opin Oncol. 1991. PMID: 1684293 Review.

7

Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients.

Siena S, Bregni M, Brando B, Belli N, Ravagnani F, Gandola L, Stern AC, Lansdorp PM, Bonadonna G, Gianni AM. Siena S, et al. Blood. 1991 Jan 15;77(2):400-9. Blood. 1991. PMID: 1702334 Free article.

8

Primary and salvage chemotherapy in advanced Hodgkin's disease: the Milan Cancer Institute experience.

Bonadonna G, Santoro A, Gianni AM, Viviani S, Siena S, Bregni M, Zucali R, Lombardi F, Bonfante V, Gianni L, et al. Bonadonna G, et al. Among authors: siena s. Ann Oncol. 1991 Jan;2 Suppl 1:9-16. doi: 10.1093/annonc/2.suppl_1.9. Ann Oncol. 1991. PMID: 1710489 Free article. Review.

9

Methodologies to estimate circulating hematopoietic progenitors for autologous transplantation in cancer patients.

Ravagnani F, Siena S, Bregni M, Brando B, Belli N, Lansdorp PM, Notti P, Pellegris G, Gianni AM. Ravagnani F, et al. Among authors: siena s. Haematologica. 1991 Mar;76 Suppl 1:46-9. Haematologica. 1991. PMID: 1713874 Review.

10

Circulating hemopoietic progenitors mobilized by cancer chemotherapy and by rhGM-CSF in the treatment of high-grade non-Hodgkin's lymphoma.

Bregni M, Siena S, Magni M, Bonadonna G, Gianni AM. Bregni M, et al. Among authors: siena s. Leukemia. 1991;5 Suppl 1:123-7. Leukemia. 1991. PMID: 1716335 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

445 results

Search Page

Filters